AbbVie
Trade AbbVie 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
Stock Snapshot
The current AbbVie(ABBV) stock price is $251.78, with a market capitalization of 460.24B. The stock trades at a price-to-earnings (P/E) ratio of 129.86 and offers a dividend yield of 2.56%.
On 2026-07-31, AbbVie(ABBV) stock traded between a low of $244.78 and a high of $258.00. Shares are currently priced at $251.78, which is +2.9% above the low and -2.4% below the high.
AbbVie(ABBV) shares are trading with a volume of 1.59M, against a daily average of 5.42M.
During the past year, AbbVie(ABBV) stock moved between $187.62 at its lowest and $267.47 at its peak.
During the past year, AbbVie(ABBV) stock moved between $187.62 at its lowest and $267.47 at its peak.
ABBV News
AbbVie shares are under pressure. Why are ABBV shares declining? A Guidance Trim Overshadows a Clean Earnings Beat Adjusted diluted earnings came in at $3.65 pe...
...
(RTTNews) - While reporting financial results for the second quarter on Friday, biopharmaceutical company AbbVie, Inc. (ABBV) trimmed its adjusted earnings guid...
Analyst ratings
75%
of 32 ratingsMore ABBV News
(RTTNews) - AbbVie (ABBV) revealed earnings for its second quarter that Increases, from the same period last year The company's bottom line totaled $3.613 bill...
(RTTNews) - AbbVie (ABBV) will host a conference call at 9:00 AM ET on July 31, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to...
Abbvie (ABBV) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident invest...
Abbvie (ABBV) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident invest...
Key Points Revolution Medicines has a promising cancer drug in development. Even with this medicine's prospects, the stock's valuation looks too frothy. 10 s...
Key Points AbbVie successfully transitioned away from Humira over the past three years. It still looks cheap relative to its long-term growth potential. It h...
Over the last 7 days, the United States market has experienced a 1.5% decline, although it remains up by 16% over the past year with earnings forecasted to grow...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.